These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11062697)

  • 1. Telomerase activity, Myc and Bcl-2: possible indicators of effective therapy of prostate cancer with 9-nitrocamptothecin.
    Chatterjee D; Wyche JH; Romero DP; Pantazis P
    Anticancer Res; 2000; 20(5A):2885-9. PubMed ID: 11062697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of human prostate tumor xenografts in nude mice and response to 9-nitrocamptothecin in vivo and in vitro does not correlate with the expression of various apoptosis-regulating proteins.
    Pantazis P; Chatterjee D; Wyche J; DeJesus A; Early J; Plaschke S; Giovanella B
    J Exp Ther Oncol; 1996 Sep; 1(5):322-33. PubMed ID: 9414421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S; Kyo S; Banerjee PP
    Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
    Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
    Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
    Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H
    Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of 9-nitrocamptothecin-triggered apoptosis in DU-145 human prostate cancer cells by ectopic expression of 14-3-3zeta.
    Chatterjee D; Goldman M; Braastad CD; Darnowski J; Wyche JH; Pantazis P; Goodglick L
    Int J Oncol; 2004 Aug; 25(2):503-9. PubMed ID: 15254750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
    Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
    Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.
    Devi GR; Oldenkamp JR; London CA; Iversen PL
    Prostate; 2002 Nov; 53(3):200-10. PubMed ID: 12386920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents.
    Vilenchik M; Raffo AJ; Benimetskaya L; Shames D; Stein CA
    Cancer Res; 2002 Apr; 62(7):2175-83. PubMed ID: 11929841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of human breast carcinoma tumors in immunodeficient mice treated with 9-nitrocamptothecin: differential response of nontumorigenic and tumorigenic human breast cells in vitro.
    Pantazis P; Early JA; Kozielski AJ; Mendoza JT; Hinz HR; Giovanella BC
    Cancer Res; 1993 Apr; 53(7):1577-82. PubMed ID: 8453626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis-related gene expression affected by a GnRH analogue without induction of programmed cell death in LNCaP cells.
    Angelucci C; Iacopino F; Lama G; Capucci S; Zelano G; Boca M; Pistilli A; Sica G
    Anticancer Res; 2004; 24(5A):2729-38. PubMed ID: 15517879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 9-Nitrocamptothecin is an effective drug for the treatment of human lung tumors: comparison of in vitro and in vivo studies.
    Han Z; Wyche JH; Sands H; Pantazis P
    Anticancer Res; 2001; 21(3B):1823-7. PubMed ID: 11497265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
    Zupi G; Scarsella M; Semple SC; Mottolese M; Natali PG; Leonetti C
    Clin Cancer Res; 2005 Mar; 11(5):1990-8. PubMed ID: 15756025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
    Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW
    Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camptothecin and 9-nitrocamptothecin (9NC) as anti-cancer, anti-HIV and cell-differentiation agents. Development of resistance, enhancement of 9NC-induced activities and combination treatments in cell and animal models.
    Pantazis P; Han Z; Balan K; Wang Y; Wyche JH
    Anticancer Res; 2003; 23(5A):3623-38. PubMed ID: 14666658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
    Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; Newbold RF; Nabholz M; Lingner J
    Cancer Res; 2001 Oct; 61(20):7594-602. PubMed ID: 11606399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of telomerase activity and bcl-2 expression in berbamine-induced apoptosis in HL-60 cells.
    Ji ZN; Ye WC; Liu GQ; Huang Y
    Planta Med; 2002 Jul; 68(7):596-600. PubMed ID: 12142991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multistage process of carcinogenesis in human esophageal epithelial cells induced by human papillomavirus.
    Shen ZY; Xu LY; Li EM; Cai WJ; Shen J; Chen MH; Cen S; Tsao SW; Zeng Y
    Oncol Rep; 2004 Mar; 11(3):647-54. PubMed ID: 14767516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro and in vivo studies on the biologic effects and molecular mechanism of recombinant RA538 and antisense C-myc adenovirus on human gastric, esophageal and cancer cell lines with high-expression of Bcl-2 gene].
    Chen JP
    Sheng Li Ke Xue Jin Zhan; 1999 Jul; 30(3):227-30. PubMed ID: 12532785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.